Etiology and complications of liver cirrhosis: Data from a German centre;Ätiologie und Komplikationen der Leberzirrhose: Daten eines deutschen Zentrums

Deutsche Medizinische Wochenschrift

Volumn 139, Issue 36, 2014, Pages 1758-1762

  Sivanathan, V ^a   Kittner, J M ^a   Sprinzl, M F ^a   Weinmann, A ^a   Koch, S ^a   Wiltink, J ^a   Nguyen Tat, M ^a   Marquardt, J U ^a   Worns M A ^a   Zimmermann, T ^a   Lang, H ^a   Galle, P R ^a   Schattenberg, J M ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

complications; etiology; infection; liver cirrhosis; liver transplantation; pharmacotherapy; portal hypertension

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ASCITES; CHILD TURCOTTE PUGH SCORE; DECOMPENSATED LIVER CIRRHOSIS; ESOPHAGUS VARICES; FEMALE; GERMANY; GRAM POSITIVE INFECTION; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFECTION RISK; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OUTPATIENT CARE; PLEURA EFFUSION; QUESTIONNAIRE; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BACTERIAL INFECTIONS; CAUSALITY; COMORBIDITY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GERMANY; HEPATIC ENCEPHALOPATHY; HEPATITIS, VIRAL, HUMAN; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84906708147     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0034-1387240     Document Type: Article

References (30)

1. Anstee Q. M., Daly A. K., Day C. P. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis: 2011; 31 128 146
2. Baumeister S. E., Volzke H., Marschall P. et al. Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology: 2008; 134 85 94
3. Bellentani S., Tiribelli C., Saccoccio G. et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology: 1994; 20 1442 1449
4. Blachier M., Leleu H., Peck-Radosavljevic M. et al. The burden of liver disease in Europe. J Hepatol: 2013; 58 593 608
5. Chalasani N., Younossi Z., Lavine J. E. et al. The diagnosis and management of non-alcoholic fatty liver disease. Gastroenterology: 2012; 142 1592 1609
6. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. J Hepatol: 2006; 44 217 231
7. El-Serag H. B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma. Clin Gastroenterol Hepatol: 2006; 4 369 380
8. Fagiuoli S., Colli A., Bruno R. et al. Management of infections in cirrhotic patients. Dig Liver Dis: 2014; 46 204 212
9. Fernandez J., Gustot T. Management of bacterial infections in cirrhosis. J Hepatol: 2012; 56 (01) S1 12
10. Fernandez J., Navasa M., Gomez J. et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology: 2002; 35 140 148
11. Gundling F., Schumm-Draeger P. M., Schepp W. [Hepatogenous diabetes - diagnostics and treatment]. Z Gastroenterol: 2009; 47 436 445
12. Jalan R., Fernandez J., Wiest R. et al. Bacterial infections in cirrhosis. J Hepatol: 2014; 60 1310 1324
13. Mandorfer M., Bota S., Schwabl P. et al. Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology: 2014; 146 1680 1690 e1681
14. Mendall M. A., Strachan D. P., Butland B. K. et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Europ Heart J: 2000; 21 1584 1590
15. Merli M., Lucidi C., Di Gregorio V. et al. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int: 2014; 10.1111/liv.12593
16. Nardone A., Anastassopoulou C. G., Theeten H. et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect: 2009; 137 961 969
17. Ott J. J., Stevens G. A., Groeger J. et al. Global epidemiology of hepatitis B virus infection. Vaccine: 2012; 30 2212 2219
18. Peleg A. Y., Weerarathna T., McCarthy J. S. et al. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev: 2007; 23 3 13
19. Poethko-Muller C., Zimmermann R., Hamouda O. et al. [Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz: 2013; 56 707 715
20. RKI Robert-Koch-Institut: Virushepatitis B, C und D im Jahr 2010. Epid Bull: 2011; 29 261 274
21. RKI Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2012. Robert Koch Institut Datenstand: 01 03 2013; http://www.rki.de/ DE/Content/Infekt/Jahrbuch/Jahrbuch-2012.pdf?-blob=publicationFile
22. Schuppan D., Afdhal N. H. Liver cirrhosis. Lancet: 2008; 371 838 851
23. Schuppan D., Schattenberg J. M. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol: 2013; 28 01 68 76
24. Seitz H. K., Stickel F. Alkohol-induzierte Hepatitis. Dtsch Med Wochenschr: 2013; 138 2041 2044
25. Senzolo M., Cholongitas E., Burra P. et al. beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int: 2009; 29 1189 1193
26. Statistisches Bundesamt Todesursachen in Deutschland. Fachserie 12 Reihe 4 - 2012. https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/ Todesursachen/Todesursachen.html
27. Taneja S. K., Dhiman R. K. Prevention and management of bacterial infections in cirrhosis. Int J Hepatol: 2011; Epub 2011 Aug 28 10.4061/2011/784540
28. WHO European Status Report on Alcohol and Health. 2010; http://www.euro.who.int/-data/assets/pdf-file/0004/128065/e94533.pdf
29. Wiegand J., Berg T. The etiology, diagnosis and prevention of liver cirrhosis. Dtsch Arztebl Int: 2013; 110 85 91
30. Wong R. J., Cheung R., Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology: 2013; 10.1002/hep.26986